1907 Results
Staff Scientist julie.gilbert@cancercare.on.ca
Drug
Jul 2020
Guidelines and Advice
Status: Current
ID: GL-C50-26
ID: GL-C50-26
Feb 2016
Drug
Apr 2023
Guidelines and Advice
Status: Current
Version: 2
Version: 2
Dec 2021
Guidelines and Advice
Status: In-Review
ID: GL END 3-23
Version: N/A
ID: GL END 3-23
Version: N/A
Oct 2021
Drug
Other Name(s): Megace® (multiple brands available)
Aug 2016
Drug
Sep 2018
